Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioMérieux, headquartered in France, is a global pioneer in in-vitro diagnostics. The company develops and distributes innovative diagnostic solutions for infectious diseases and microbiology. BioMérieux significantly contributes to improving patient health and consumer safety by delivering precise and rapid results.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioMerieux is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioMerieux last reported quarterly earnings on 7/28/2026 (Q2 2026). Earnings per share (EPS) came in at 1.99 EUR.
Across its last 3 earnings reports, BioMerieux stock moved by ±7.5% on average the following day. The largest reaction was -17.5% on 04/23/2026; 1 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.